3NAZNEENS LIMITED

3NAZNEENS LIMITED

Statement of Financial Position

As at 30 November 2025

	£	2025 £	£	2024 £
Fixed assets		1,570		851
Current assets	282,594		288,962
Creditors: amount falling due within one year	(14,695)		(22,755)
Net current assets/(liabilities)		267,899		266,207
Total assets less current liabilities		269,469		267,058
Accruals and deferred income		(174)		(174)
Net assets/(liabilities)		269,295		266,884


Capital and reserves		269,295		266,884

Notes to the Accounts

Statutory Information

3Nazneens Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number 10473893, registration address Apollo House, Hallam Way, Whitehills Business Park, Blackpool, FY4 5FS, England.

The presentation currency is £ sterling.

1.	Accounting Policies Basis of accounting The financial statements are prepared under the historical cost convention and in accordance with the FRS 105 Financial Reporting Standard for Micro Entities (effective January 2016).

2.	Average number of employees Average number of employees during the year were 2 (2024: 2).

3.	Director Advances Credits Note At 30th November 2025 the director owed 3NAZNEENS LIMITED £32,293 (£32,466 at 30th November 2024). The loan is interest bearing, unsecured and has no set repayment terms.

Director's Responsibilities:

For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The financial statements have been prepared in accordance with the micro-entity provisions.

Signed on behalf of the board of directors:

---------------------------------------------

Amar Masood Siddiqui
Director

Date approved: 25 July 2026